Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Equity (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Return on Equity readings, the most recent being 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Treace Medical Concepts, down from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2021 to a low of 0.98% in Q1 2021.
  • Median Return on Equity over the past 5 years was 0.0% (2022), compared with a mean of 0.05%.
  • Biggest five-year swings in Return on Equity: decreased -5bps in 2021 and later skyrocketed 97bps in 2022.
  • Treace Medical Concepts' Return on Equity stood at 0.0% in 2021, then tumbled by -186bps to 0.01% in 2022, then skyrocketed by 41bps to 0.0% in 2023, then tumbled by -42bps to 0.01% in 2024, then decreased by -25bps to 0.01% in 2025.
  • The last three reported values for Return on Equity were 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.